RxDoctor Payments Data

Brady Laughlin, DO

Diagnostic Radiology · Wilmington, DENPI 1326401126

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,536 of the $5,132 with a category attached, or 88.4%. 17 manufacturers reported payments, led by Boston Scientific at 33.9% of the total. Among diagnostic radiology clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,132in general payments, 2019–2025

Across 79 payments — averaging $64.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Medtronic$1K
  • Penumbra, Inc.$533
  • Nevro Corp.$437
  • Balt USA, LLC$292
  • Terumo Medical Corporation$185
  • plus $901 from 11 others

What the payments were for

  • Travel & lodging$59712%
  • Food & beverage$4,53688%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,132 in reported general payments places this provider in the 95th percentile of 98 diagnostic radiology providers in Delaware.

See all diagnostic radiology providers in Delaware

Medicare billing

Part B allowed, 2024
$91,442
Medicare patients
815
Services billed
1,316

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate12$104

Paid to pharmacies, not to this prescriber.

Other diagnostic radiology in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →